Navigation Links
Hypertension drugs could lower Disability

According to reseasrches, drugs used to treat hypertension could delay muscle loss and disability in seniors. Dr.Graziano Onder, research associate at University of Hopkins has suggested new, beneficial effects of (Angiotensin Converting Enzyme) ACE-inhibitor //drugs, which are widely used for hypertension, beneficial effects on muscle strength and overall physical performance in older adults. This research must be confirmed in future clinical trials.

The Food and Drug Administration has approved such ACE inhibitors as Accupril, Captopril, Altace and Vasotec. The retrospective study at Hokins, published in the medical journal The Lancet, involved analysis of three years of data from 1995 to 1999 on 650 hypertensive and partially disabled women over 60 who participated in the Women's Health and Aging Study, a project of the National Institute on Aging in Bethesda, Md.

The women on continuous ACE inhibitor therapy showed slower loss of walking speed and muscle strength compared to those using other hypertension drugs or using none. During repeated testing over the three-year period, the subjects walking speeds were measured and they were graded on muscle strength.

Correlating that data to pharmaceutical records, the researchers found women on continuous ACE inhibitor therapy had a lower average decline in muscle strength of 2.5 pounds over the three years, as compared to intermittent users of other antihypertensive drugs, at 7.5 pounds and non-users at minus 8.1 pounds.

Continuous ACE inhibitor users had a smaller loss in walking speed -- sixth-tenths of an inch per second compared with intermittent users of ACE inhibitors at 5.3 inches per second, 6.1 inches per second for intermittent users of other antihypertensive drugs and 7 inches per second for non-users.

"If these findings can be confirmed in randomized controlled trials, ACE inhibitors could not only be used as first-line treatment of older adults with h ypertension, but could also be used to slow physical decline in elderly people," Onder said. "However, pharmaceutical companies are not very interested in ACE-inhibitors right now."

ACE inhibitors have been on the market for more than 10 years, he added, and patents are soon expiring. Onder said he would seek governmental grant funding for a new clinical trial. Dr. Marjolein Visser, assistant professor of medicine suggested that muscle strength and loss of muscle strength is such an important factor in the development of disability in old age. The next step will be to find out whether the same results are obtained from a non-disabled population, to see whether people who use these common medications might actually delay the onset of disability in old age.


'"/>




Related medicine news :

1. New viewpoint on Hypertension
2. FDA Approves Remodulin for Pulmonary Hypertension
3. Glaucoma & Ocular Hypertension more likely in patients with refractive errors
4. Hypertension lowered by Bedtime Dosing
5. Better Treatment For Hypertension
6. Treating Pulmonary Arterial Hypertension In Children With Viagra
7. Hypertension Drug of Choice for African Americans
8. Hypertension can be caused by Inhalation of Salt
9. Inhaling Salt Can Lead To Hypertension
10. Elderly Women Remain At Risk From Hypertension
11. Elderly Women Remain At Risk From Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... , ... 10 Best Water is excited to announce a new ... that topped the list as a result of their commitment to offering clients creative, ... Tibet 5100, a top notch water company that specializes in providing the public with ...
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ravages of traumatic ... to conduct a survey that takes a closer look at cases of TBI being ... and causes of TBI among the aging population, and identifies the challenges associated with ...
(Date:2/10/2016)... ... ... Gout is like no other joint pain. It strikes suddenly, like flicking on ... redness. It is triggered by the crystallization of uric acid within the joints. It ... to the February 2016 issue of Harvard Men's Health Watch. , The large joint ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The Association ... inspirational speaker Jan Fox will serve as keynote speaker at the organization’s 2016 ... with tools to more effectively communicate with their own organizational staff and leadership. ...
(Date:2/10/2016)... ... February 10, 2016 , ... A ... Ohio Safety Congress and Expo event March 9-11, 2016. Hosted by Ohio's Bureau ... Center. , As the longest running and largest worker's compensation event in ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... Israel , Feb. 11, 2016  Galmed Pharmaceuticals Ltd. ... company focused on the development of a once-daily, oral ... that its Chief Medical Officer, Dr. Maya Halpern ... Galmed as Chief Medical Officer and from its Board ... to her reaching retirement age. Allen Baharaff ...
(Date:2/11/2016)... Hungary , Feb. 11, 2016 ... the unmet medical need of pulmonary and respiratory diseases ... The program focusing on COPD and asthma patients show ... --> --> Upper ... healthcare problems in the developed world and reached epidemic ...
(Date:2/11/2016)... February 11, 2016 ,   ... EUR 1,377.2m  Adjusted EBITDA climbs to EUR 277.9m   ... 3.41  Proposed dividend of EUR 0.85 per share (2014: ... tubing business and refinancing successfully completed  Approximately 9% ... organic basis  Adjusted EBITDA expected for 2016 at ...
Breaking Medicine Technology: